Hadassah to conduct clinical trial of Israeli-made Covid-19 vaccine

One hundred volunteers are being recruited for the trial, slated to begin in October at Hadassah and Tel Aviv's Sheba Medical Center. Read more

Drug developed by Hadassah doctor helps severely ill Covid-19 patients

Hadassah Hospital successfully treated five seriously-ill COVID-19 patients using an experimental treatment. All five patients tested negative to coronavirus and have now been discharged. Read more

The little things can make a big difference: Mental health during the COVID pandemic

Mental health experts from Australia and Israel discussed on Monday some of the consequences of COVID-19 and the practical ways to support one another through the crisis. Read more

Uncovering New Ways to Treat Kidney Disease in Children

Dr Oded Volovelsky, head of Hadassah's pediatric nephrology unit, appeared on an episode of the podcast On Call, to discuss his research helping to treat children with kidney disease. Read more

Six Hadassah researchers receive major grants from Israel Science Foundation

Researchers at the Hadassah received six of the eight coveted awards granted this year by the Israel Science Foundation, the Israeli agency that supports breakthrough basic science in various fields of knowledge. Read more

Hadassah treats COVID-19 patient with new concentrated passive vaccine

The antibody (immunoglobulin or IgG) concentrate was developed using plasma that Hadassah harvested from recovered corona patients. Read more

Hadassah Researchers Find Source of Corona Blood Clots

Professor Abd Higazi, along with his team, made an incredible breakthrough in understanding a puzzling complication in coronavirus patients. Read more

Hadassah's Wohl Institute provides tools for researchers to advance

In the six months since opening, the Wohl Institute has already made waves in the medical research community for its sophisticated equipment and wide scope of projects. Read more

Secrets of the heart revealed

Hadassah Medical Center geneticists and physicians joined forces to establish the cause of two closely related tragedies. Using the latest technology, they discovered a genetic mutation that is responsible for a fatal aortic rupture. Read more

Canonic Will Conduct Pre-Clinical Studies into Cannabis at Hadassah

Hadasit, the Hadassah Medical Center’s Technology Transfer Company, has formed a partnership to conduct pre-clinical studies to support the development of anti-inflammatory medical cannabis products. Read more

Hadassah Endocrinologist Aims to Improve Life for Type 1 Diabetics

Prof. Pollak was recently awarded funding for a pre-clinical joint project to explore why type 1 diabetics are far more likely to have fragile bones than non-diabetics as they age. Read more

The Wohl Institute for Translational Medicine is Inaugerated at Hadassah Medical Center in Jerusalem

This new multidisciplinary institute is the result of a partnership between the Wohl Legacy, Hadassah International UK, and the Hadassah Medical Organization. Read more

Hadassah-Microsoft team diagnoses Parkinson's, raising ethical dilemmas

Hadassah Medical Organization doctors working with Microsoft researchers reported they were often able to diagnose Parkinson’s disease simply from the way people seeking information about the disease typed on their computer and moved their mouse. Read more

Hadassah Study Sheds Encouraging Light in Treating Liver Disease

The International Journal of Molecular Medicine has published a preclinical study led by Prof. Rifaat Safadi, head of the Hadassah Medical Center’s Liver Unit, that finds the oral drug Namodenoson induced significant anti-inflammatory, anti-steatotic (retention of lipids), and anti-fibrotic (scarring) effects caused by non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Read more